GO:1900108 negative regulation of nodal signaling pathway: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900108 describes any process that stops, prevents, or reduces the frequency, rate, or extent of Nodal signaling, a TGF-beta superfamily pathway essential for mesendoderm induction and left-right axis patterning.
• Negative regulation of Nodal signaling is achieved by extracellular antagonists, intracellular feedback inhibitors such as SRF and TARAM-A, and receptor-level modulation.
• Dysregulated Nodal signaling is linked to congenital heart defects, ovarian follicular atresia, and various cancers.
• Key experimental models include Xenopus embryos, zebrafish, and mammalian cell lines, with CRISPR knockout, point mutation, knock-in, and overexpression approaches available.
• Studying this process requires methods such as RNA-seq, ChIP-seq, proteomics, and imaging to capture dynamic signaling changes.
• EDITGENE provides custom CRISPR cell models and library screening to dissect negative regulation of Nodal signaling in disease contexts.
Description
The Gene Ontology term GO:1900108, negative regulation of nodal signaling pathway, refers to any process that stops, prevents, or reduces the frequency, rate, or extent of Nodal signaling. Nodal signaling is a conserved TGF-beta superfamily pathway that plays critical roles in embryonic development, including mesendoderm formation, left-right asymmetry, and organogenesis. Understanding how this pathway is negatively regulated is essential for deciphering developmental disorders and cancer progression. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of the mechanisms, genes, and experimental methods associated with GO:1900108.
negative regulation of nodal signaling pathway At A Glance
| GO ID | GO:1900108 |
|---|---|
| GO term | negative regulation of nodal signaling pathway |
| Ontology | biological_process |
| Synonym | inhibition of nodal signaling; downregulation of nodal signaling pathway; negative regulation of nodal signalling pathway |
| Major function | Attenuation or termination of Nodal signaling to control developmental and homeostatic processes |
| Related pathway | TGF-beta signaling, Activin/Nodal signaling |
| Key regulators | SRF, TARAM-A, extracellular antagonists (e.g., Cerberus, Lefty) |
| Disease relevance | Congenital heart defects, ovarian follicular atresia, cancer |
| Experimental models | Xenopus, zebrafish, mammalian cell lines, CRISPR-edited models |
What Is GO:1900108?
GO:1900108 is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of nodal signaling pathway. It encompasses molecular events that dampen or shut down signal transduction initiated by Nodal ligands, which normally activate SMAD2/3-dependent transcription. This negative regulation can occur at multiple levels, including extracellular ligand sequestration, receptor inhibition, and intracellular feedback loops.
Why Is negative regulation of nodal signaling pathway Important in Cell Biology?
Negative regulation of Nodal signaling is crucial for proper embryonic development and tissue homeostasis. Imbalance in this regulation can lead to severe congenital defects such as heart malformations and contribute to diseases like ovarian follicular atresia and cancer. Understanding the molecular players and mechanisms provides insights into developmental biology and potential therapeutic targets.
• Controls mesendoderm formation and left-right axis patterning during embryogenesis.
• Prevents excessive Nodal signaling that could lead to developmental abnormalities.
• Dysregulation is associated with congenital heart defects.
• Implicated in ovarian follicular atresia and reproductive disorders.
• Plays a role in cancer progression by modulating TGF-beta superfamily signaling.
• Provides targets for therapeutic intervention in developmental and oncological diseases.
• Essential for understanding stem cell differentiation and organoid development.
• Helps elucidate feedback mechanisms in TGF-beta signaling networks.
• Offers a model for studying negative feedback in signaling pathways.
• Facilitates cross-species comparative studies of developmental pathways.
What Happens During negative regulation of nodal signaling pathway?
Extracellular Sequestration of Nodal Ligands
In simple terms: Proteins outside the cell bind to Nodal and prevent it from reaching its receptors.
Negative regulation of Nodal signaling can begin in the extracellular space, where secreted antagonists such as Cerberus and Lefty bind Nodal ligands, preventing them from interacting with type I and type II receptors. This sequestration reduces the effective concentration of active Nodal, thereby dampening downstream SMAD2/3 phosphorylation and transcriptional responses.
Receptor-Level Inhibition
In simple terms: Decoy receptors or inhibitory proteins block the activation of Nodal receptors.
At the cell membrane, negative regulators such as TARAM-A, a TGF-beta-related type I receptor, can interfere with Nodal receptor complexes. TARAM-A regulates Nodal signaling and mesendoderm formation, acting as a negative modulator in specific contexts. Additionally, inhibitory SMADs (I-SMADs) such as SMAD7 can recruit ubiquitin ligases to degrade activated receptors, terminating signaling.
Intracellular Feedback by SRF
In simple terms: Inside the cell, transcription factors like SRF turn off genes that keep Nodal signaling active.
SRF (Serum Response Factor) has been shown to negatively regulate Activin/Nodal signaling during Xenopus gastrulation. SRF interferes with the transcriptional activity of SMAD2/3 complexes, thereby reducing the expression of Nodal target genes. This intracellular feedback ensures timely termination of signaling during critical developmental windows.
Transcriptional Repression of Nodal Pathway Components
In simple terms: Cells can reduce the production of proteins needed for Nodal signaling.
Negative regulation also occurs through transcriptional repression of Nodal ligands, receptors, or co-factors. For example, the Ras-AP-1 signaling pathway regulates DNA methyltransferase, which can affect gene expression programs including those in TGF-beta signaling. Although direct evidence for Nodal gene repression by AP-1 is limited, cross-talk with other pathways can modulate Nodal signaling output.
Cross-Talk with Other Signaling Pathways
In simple terms: Other signaling pathways can interfere with Nodal signaling to fine-tune its activity.
Negative regulation of Nodal signaling is influenced by cross-talk with pathways such as Wnt/beta-catenin and Akt-TOR. The Yin-Yang of TCF/beta-catenin signaling illustrates how context-dependent interactions can either enhance or suppress TGF-beta family signaling. Similarly, dynamic negative feedback in Akt-TOR signaling demonstrates how cells integrate multiple inputs to control pathway activity.
Key Genes Involved in GO:1900108 negative regulation of nodal signaling pathway
The following genes and proteins are key players in the negative regulation of Nodal signaling, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SRF | Transcription factor that negatively regulates Activin/Nodal signaling during gastrulation | Studied in Xenopus for developmental roles |
| TARAM-A | TGF-beta-related type I receptor that modulates Nodal signaling and mesendoderm formation | Implicated in regulation of Nodal signaling |
| SMAD7 | Inhibitory SMAD that recruits ubiquitin ligases to degrade activated receptors | General negative regulator of TGF-beta superfamily signaling |
| Cerberus | Secreted antagonist that binds Nodal ligands | Extracellular inhibitor of Nodal signaling |
| Lefty | Secreted antagonist that binds Nodal ligands | Feedback inhibitor of Nodal signaling |
| SMAD2 | Receptor-regulated SMAD; effector of Nodal signaling | Target of negative regulation |
| SMAD3 | Receptor-regulated SMAD; effector of Nodal signaling | Target of negative regulation |
| SMAD4 | Co-SMAD; common mediator of TGF-beta signaling | Central node for pathway output |
| FOXH1 | Transcription factor that partners with SMAD2/3 | Mediates Nodal target gene activation |
| Nodal | Ligand of the pathway | Subject to negative regulation at multiple levels |
| Activin | Related ligand that shares receptors with Nodal | Cross-regulates Nodal signaling |
| DNA methyltransferase | Enzyme regulated by Ras-AP-1 pathway | Potential indirect regulator of Nodal pathway genes |
| Akt | Kinase in Akt-TOR pathway | Cross-talk with Nodal signaling |
| TOR | Kinase in Akt-TOR pathway | Cross-talk with Nodal signaling |
| TCF | Transcription factor in Wnt pathway | Cross-talk with TGF-beta signaling |
| beta-catenin | Transcription co-activator in Wnt pathway | Cross-talk with TGF-beta signaling |
| AP-1 | Transcription factor complex | Regulates DNA methyltransferase, potential indirect effect |
| Ras | Small GTPase | Upstream of AP-1, potential indirect regulator |
How Is negative regulation of nodal signaling pathway Regulated?
Negative regulation of Nodal signaling is itself tightly regulated. Feedback loops involving Lefty and Cerberus are induced by Nodal signaling and subsequently inhibit the pathway, creating a self-limiting circuit. SRF provides an additional layer of negative feedback by interfering with SMAD2/3 transcriptional activity. Cross-talk with Akt-TOR and Wnt/beta-catenin pathways further modulates the strength and duration of Nodal signaling. These regulatory mechanisms ensure precise spatial and temporal control during development.
negative regulation of nodal signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Nodal | Congenital heart defects | CRISPR knockout in human iPSC-derived cardiomyocytes |
| SRF | Developmental disorders | Xenopus embryo knockdown/knockout |
| TARAM-A | Mesendoderm formation defects | Zebrafish knockout |
| SMAD7 | Cancer progression | Cancer cell line overexpression |
| Lefty | Left-right asymmetry defects | Mouse knockout |
Congenital Heart Defects
Disrupted negative regulation of Nodal signaling can lead to congenital heart defects. Nodal signaling is critical for left-right asymmetry and cardiac development, and its dysregulation is associated with structural heart malformations. Mutations in genes encoding negative regulators or pathway components may contribute to these defects.
Ovarian Follicular Atresia
The Nodal/Activin receptor-like kinase 7 signaling pathway plays a role in ovarian follicular atresia. Negative regulation of this pathway is important for maintaining follicular health, and its perturbation can lead to premature ovarian failure or infertility.
Cancer
Aberrant Nodal signaling is implicated in various cancers, where it promotes cell proliferation, invasion, and stemness. Loss of negative regulation can contribute to tumor progression, making components of this regulatory network potential therapeutic targets.
From negative regulation of nodal signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate Nodal signaling? | CRISPR knockout in HEK293T or Xenopus embryos |
| What is the effect of a point mutation in gene X on Nodal inhibition? | CRISPR point mutation knock-in in cell lines |
| How does tagged gene X localize during Nodal inhibition? | Knock-in of fluorescent tag in zebrafish |
| Does overexpression of gene X suppress Nodal target genes? | Overexpression in mammalian cell lines |
| Which genes are essential for negative regulation? | CRISPR library screening in reporter cell lines |
| What are the transcriptomic changes upon loss of negative regulator? | RNA-seq after CRISPR knockout |
How to Study the negative regulation of nodal signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcript changes | Identify Nodal target genes upon regulator knockout |
| ChIP-seq | DNA binding sites of transcription factors | Map SMAD2/3 and SRF binding at target loci |
| Proteomics | Protein abundance and interactions | Discover novel negative regulators |
| Immunofluorescence | Protein localization and activation state | Visualize SMAD nuclear translocation |
| Luciferase reporter assay | Transcriptional activity of Nodal targets | Quantify pathway inhibition |
| CRISPR knockout | Loss-of-function phenotypes | Test candidate negative regulators |
| CRISPR activation | Gain-of-function phenotypes | Overexpress candidate regulators |
| Live imaging | Dynamic signaling changes | Track Nodal signaling in embryos |
Transcriptomic Analysis (RNA-seq)
RNA sequencing can reveal changes in gene expression upon perturbation of negative regulators of Nodal signaling. For example, knockout of SRF in Xenopus embryos followed by RNA-seq can identify Nodal target genes affected.
Proteomic Profiling
Mass spectrometry-based proteomics can identify protein-protein interactions and post-translational modifications in the Nodal signaling network, such as SMAD phosphorylation and ubiquitination.
Imaging and Reporter Assays
Fluorescent reporters for Nodal signaling (e.g., SMAD2/3 nuclear translocation) combined with live imaging can visualize negative regulation dynamics in real time.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens using Nodal-responsive reporter cell lines can identify novel negative regulators of the pathway.
How CRISPR Can Be Used to Study GO:1900108 negative regulation of nodal signaling pathway
Knockout
CRISPR knockout of candidate negative regulators (e.g., SRF, TARAM-A) can test whether they are required to suppress Nodal signaling. Loss of function may lead to enhanced Nodal target gene expression and developmental defects.
Point Mutation
Introducing precise point mutations in genes like SMAD7 can dissect domain-specific functions, such as ubiquitin ligase recruitment, without completely abolishing protein expression.
Knock-in
Knock-in of fluorescent or epitope tags into endogenous loci (e.g., Nodal, Lefty) allows real-time tracking of protein localization and dynamics during negative regulation.
Overexpression
CRISPR activation or cDNA overexpression of negative regulators can suppress Nodal signaling and test sufficiency in inhibiting pathway output.
How EDITGENE Supports negative regulation of nodal signaling pathway Research
Researchers studying negative regulation of nodal signaling pathway-related genes often need to determine whether a candidate gene is causally involved in dampening the pathway or is merely correlated with changes in expression. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies in relevant cell models.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of nodal signaling pathway research.
Frequently Asked Questions About negative regulation of nodal signaling pathway
What is GO:1900108?
GO:1900108 is the Gene Ontology term for negative regulation of nodal signaling pathway, describing any process that stops, prevents, or reduces Nodal signaling.
What genes are involved in negative regulation of nodal signaling pathway?
Key genes include SRF, TARAM-A, SMAD7, Cerberus, and Lefty, which act at different levels to inhibit Nodal signaling.
Why is negative regulation of Nodal signaling important?
It is crucial for proper embryonic development, preventing excessive signaling that can cause congenital defects and cancer.
What diseases are associated with dysregulated Nodal signaling?
Congenital heart defects, ovarian follicular atresia, and various cancers have been linked to disrupted Nodal signaling.
How can I study negative regulation of Nodal signaling?
Using CRISPR knockout, point mutation, knock-in, overexpression, and library screening in cell and animal models.
What model organisms are used to study Nodal signaling?
Xenopus, zebrafish, and mouse are common models, along with mammalian cell lines.
What is the role of SRF in Nodal signaling?
SRF negatively regulates Activin/Nodal signaling during Xenopus gastrulation by interfering with SMAD2/3 transcriptional activity.
How does TARAM-A regulate Nodal signaling?
TARAM-A is a TGF-beta-related type I receptor that modulates Nodal signaling and mesendoderm formation, acting as a negative regulator.
Can CRISPR be used to study negative regulation of Nodal signaling?
Yes, CRISPR knockout, knock-in, and overexpression are powerful tools to dissect gene function in this pathway.
What services does EDITGENE offer for Nodal signaling research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to Nodal signaling studies.
Conclusion
Negative regulation of Nodal signaling (GO:1900108) is a critical process that ensures proper developmental and homeostatic control. Dysregulation of this process is linked to congenital heart defects, reproductive disorders, and cancer. By leveraging CRISPR-based models and advanced omics, researchers can uncover novel regulators and therapeutic targets. EDITGENE offers comprehensive services to support these investigations.
References
- 1. Yun CH et al.. 2007. Negative regulation of Activin/Nodal signaling by SRF during Xenopus gastrulation.. Development 134(4):769-77 PMID: 17259304
- 2. Shen MM. 2007. Nodal signaling: developmental roles and regulation.. Development 134(6):1023-34 PMID: 17287255
- 3. Wang H et al.. 2006. Role and regulation of nodal/activin receptor-like kinase 7 signaling pathway in the control of ovarian follicular atresia.. Mol Endocrinol 20(10):2469-82 PMID: 16709598
- 4. Nakanishi T et al.. 2016. Nodal Signaling and Congenital Heart Defects.. PMID: 29787126
- 5. Barker N et al.. 2000. The Yin-Yang of TCF/beta-catenin signaling.. Adv Cancer Res 77:1-24 PMID: 10549354
- 6. Kockel L et al.. 2010. Dynamic switch of negative feedback regulation in Drosophila Akt-TOR signaling.. PLoS Genet 6(6):e1000990 PMID: 20585550
- 7. Rouleau J et al.. 1995. Regulation of the DNA methyltransferase by the Ras-AP-1 signaling pathway.. J Biol Chem 270(4):1595-601 PMID: 7829490
- 8. Aoki TO et al.. 2002. Regulation of nodal signalling and mesendoderm formation by TARAM-A, a TGFbeta-related type I receptor.. Dev Biol 241(2):273-88 PMID: 11784111
